GSK Secures mRNA Vaccines For Bird Flu, COVID And Seasonal Flu From Struggling Biotech CureVacForbes • 07/03/24
CureVac's stock soars on GSK's $1.56 billion deal for its COVID-19 and flu vaccinesMarket Watch • 07/03/24